Antibacterial and antiinflammatory kinetics of curcumin as a potential antimucositis agent in cancer patients

Nutrition and Cancer

Volumn 64, Issue 7, 2012, Pages 975-981

  Lüer, Sonja ^a   Troller, Rolf ^a   Aebi, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CURCUMIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CANCER PATIENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG SCREENING; IN VITRO STUDY; INHIBITION KINETICS; MORAXELLA CATARRHALIS; MOUTH FLORA; MUCOSA INFLAMMATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIA; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; CHEMOKINE CCL2; CURCUMIN; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MICROBIAL VIABILITY; MUCOSITIS; ORAL HEALTH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867758719     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.713161     Document Type: Article

References (29)

1. Sonis, S T. 2009. Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol, 45: 1015-1020.
2. Elting, L S, Cooksley, C, Chambers, M, Cantor, S B, Manzullo, E. 2003. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer, 98: 1531-1539.
3. Worthington, H V, Clarkson, E T, Bryan, G, Furness, S, Glenny, A M. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev, 12 CD000978. doi: 10.1002/14651858
4. Sonis, S T. 1998. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol, 34: 39-43.
5. Ratner, A J, Lysenko, E S, Paul, M N, and, Weiser, J N. 2005. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci US, 102: 3429-3434.
6. Cheng, K K, Lee, V, Li, C H, Goggins, W, Thompson, D R. 2011. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol, 47: 153-162.
7. van Vliet, M J, Harmsen, H J, de Bont, E S, and, Tissing, W J. 2010. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog, 6: e1000879
8. Napenas, J J, Shetty, K V, and, Streckfus, C F. 2007. Oral mucositis: review of pathogenesis, diagnosis, prevention, and management. Gen Dent, 55: 335-344.
9. Dubey, S K, Sharma, A K, Narain, U, Misra, K, and, Pati, U. 2008. Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. Eur J Med Chem, 43: 1837-1846.
10. Taylor, R A, and, Leonard, M C. 2010. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev, 16: 152-156.
11. Ler, S, Troller, R, Jetter, M, Spaniol, V, and, Aebi, C. 2011. Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis?. Support Care Cancer, 19: 799-806.
12. Murphy, T F. 1989. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr Infect Dis J, 8: S75-S77.
13. Stokman, M A, Spijkervet, F L, Burlage, F R, Dijkstra, P U, Manson, W L. 2003. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial. Br J Cancer, 88: 1012-1016.
14. Wijers, O B, Levendag, P C, Harms, E R, Gan-Teng, A M, Schmitz, P I. 2001. Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys, 50: 343-352.
15. Donnelly, J P, Bellm, L A, Epstein, J B, Sonis, S T, and, Symonds, R P. 2011. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis, 3: 405-412.
16. van't Land, B, Blijlevens, N M, Marteijn, J, Timal, S, Donnelly, J P. 2004. Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia, 18: 276-284.
17. Jagetia, G C, and, Aggarwal, B B. 2007. Spicing up of the immune system by curcumin. J Clin Immunol, 27: 19-35.
18. Singh, S, and, Aggarwal, B B. 1995. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem, 270: 24995-5000. [corrected]
19. Logan, R M, Gibson, R J, Sonis, S T, and, Keefe, D M. 2007. Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol, 43: 395-401.
20. Logan, R M, Stringer, A M, Bowen, J M, Gibson, R J, Sonis, S T. 2008. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther, 7: 1139-1145.
21. Strieter, R M, and, Kunkel, S L. 1993. The immunopathology of chemotactic cytokines. Adv Exp Med Biol, 351: 19-28.
22. Yadav, A, Saini, V, and, Arora, S. 2010. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta, 411: 1570-1579.
23. Luo, J, Xiong, Y, Han, X, and, Lu, Y. 2011. VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications. J Mol Med, 89: 635-645.
24. Adas, G, Percem, A, Adas, M, Kemik, O, Arikan, S. 2011. VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study). Int J Surg, 9: 467-471.
25. Bussolino, F, Wang, J M, Defilippi, P, Turrini, F, Sanavio, F. 1989. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature, 337: 471-473.
26. McKay, I A, and, Leigh, I M. 1991. Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol, 124: 513-518.
27. Dazzi, C, Cariello, A, Giovanis, P, Monti, M, Vertogen, B. 2003. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Ann Oncol, 14: 559-563.
28. McAleese, J J, Bishop K, AHern, and, Henk, J M. 2006. Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer. Br J Radiol, 79: 608-613.
29. Nemunaitis, J, Rosenfeld, C S, Ash, R, Freedman, M H, Deeg, H J. 1995. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant, 15: 949-954.